Farther Finance Advisors’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.1K	Buy	324 +133	+70%	+$3.63K	﹤0.01%	4107
2025 Q4	$5.19K	Hold	191	–	–	﹤0.01%	4291
2025 Q3	$4.94K	Buy	191 +10	+6%	+$232	﹤0.01%	3772
2025 Q2	$3.68K	Buy	181 +125	+223%	+$2.43K	﹤0.01%	3485
2025 Q1	$944	Sell	56 -64	-53%	-$1.43K	﹤0.01%	3630
2024 Q4	$3.03K	Sell	120 -203	-63%	-$5.51K	﹤0.01%	2858
2024 Q3	$11K	Buy	323 +3	+0.9%	+$114	﹤0.01%	2329
2024 Q2	$12.5K	Buy	320 +300	+1,500%	+$11.3K	﹤0.01%	1990
2024 Q1	$833	Hold	20	–	–	﹤0.01%	2840
2023 Q4	$793	Buy	20 +1	+5%	+$29	﹤0.01%	2818
2023 Q3	$523	Sell	19 -299	-94%	-$9.37K	﹤0.01%	2256
2023 Q2	$10.8K	Sell	318 -2,910	-90%	-$98.1K	﹤0.01%	1170
2023 Q1	$116K	Buy	+3,228	New	+$139K	0.03%	366